10/15/2026
New Study Reveals Why Bacterial Vag/osis Keeps Coming Back 🔬
For years, recurrent bacterial vag/nosis (BV) has been a frustrating challenge for patients and healthcare professionals alike. Even after completing antibiotics, many women experience another episode, sometimes within weeks.
Now, emerging research is helping explain why treatment doesn't always lead to lasting results.
A landmark 2025 clinical trial found that treating male partners alongside women with BV significantly reduced recurrence. Within 12 weeks, BV returned in 35% of women whose partners were also treated, compared with 63% receiving standard treatment alone.
But researchers uncovered another important piece of the puzzle: not every recurrence is caused by reinfection.
Some BV-associated bacteria may survive the initial treatment, preventing the vag/nal microbiome from fully recovering. Others may be reintroduced through s//xual contact after treatment. These two pathways can also overlap.
In a follow-up investigation involving 188 couples, researchers found that women showing signs of persistent BV-associated bacteria after treatment were nearly three times more likely to experience recurrence within four weeks.
These findings challenge the idea that recurrent BV can be addressed with a single, standardized approach. They also highlight why understanding the vag/nal microbiome, bacterial persistence, and partner-related transmission matters when developing more effective treatments.
For s//xual health professionals, the implications extend beyond prescribing antibiotics. They reinforce the importance of individualized care, evidence-based education, and staying informed as research evolves.
Want to strengthen your expertise in human s//xuality and s//xual health? Take our 30-second “QUIZ” to discover which SHA Certification aligns with your professional goals.